Smith & Nephew Acquires Integrity Orthopaedics

Smith & Nephew Acquires Engage Surgical

January 19, 2022

Medical Devices

Smith & Nephew plc has acquired Orlando-based Engage Surgical, a maker of cementless unicompartmental (partial) knee systems, in a transaction worth up to $135 million (contingent payments). The deal, financed from existing cash and debt facilities, secures unique cementless partial-knee technology for Smith & Nephew to support its Robotics and Real Intelligence strategy and growth in the partial-knee market.

Smith+Nephew Acquires CartiHeal for up to $330 Million

November 24, 2023

Medical Devices

Smith+Nephew (S&N) has agreed to acquire Israeli medtech CartiHeal for up to $330 million, adding CartiHeal's Agili‑C implant to its Sports Medicine/knee repair portfolio. CartiHeal, founded in 2009 and headquartered in Kfar Saba, Israel, employs about 25 people and has FDA breakthrough-designated technology for osteochondral repair.

All Star Healthcare Solutions Acquires Integrity Locums

May 6, 2025

Healthcare Services

All Star Healthcare Solutions, a Deerfield Beach-based full-service locum tenens and permanent placement staffing firm, has acquired Integrity Locums, an Englewood-based locum tenens staffing firm. The deal expands All Star's coverage capacity and specialty offerings nationwide and is the company's first acquisition since partnering with growth investor Knox Lane in May 2024.

SI Solutions Acquires Integrity Specialists, LLC

September 2, 2025

Industrial Services

SI Solutions, LLC (backed by MidOcean Partners) has acquired Integrity Specialists, LLC, a provider of advanced non-destructive examination (NDE) and pipeline inspection services based in Annandale, Minnesota. The acquisition expands SI Solutions' NDE and pipeline integrity capabilities and scales its services to the natural gas midstream market as part of its platform growth.

Integra LifeSciences Acquires Acclarent, Inc.

April 1, 2024

Medical Devices

Integra LifeSciences Holdings Corporation has completed its acquisition of Acclarent, Inc., a maker of ear, nose and throat (ENT) surgical devices. The transaction expands Integra’s product portfolio into the ENT device segment, adding approximately $1 billion to the company’s total addressable market and providing scale through Acclarent’s commercial and R&D capabilities.

Integra LifeSciences Acquires Surgical Innovation Associates (SIA)

December 1, 2022

Medical Devices

Integra LifeSciences agreed to acquire Surgical Innovation Associates (SIA), the developer of DuraSorb, a resorbable synthetic matrix for plastic and reconstructive (including implant-based breast) surgery. Integra will pay $50 million at closing with up to $90 million in contingent consideration to support its expansion into breast reconstruction and strengthen its soft tissue reconstruction portfolio.